Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
LUCD
#3533
Lucid Diagnostics Inc. Common Stock
1.3
5
USD
+5.47%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+5.47%
Aylık Değişim
-3.57%
6 aylık değişim
+12.50%
Yıllık Değişim
+11.57%
Önceki Kapanış
1.2
8
Open
1.3
5
Bid
Ask
Low
1.3
5
High
1.3
5
Hacim
23
Piyasalar
ABD Borsası
Sağlık Hizmetleri
LUCD
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
37.43 M
43.39 M
48.24 M
90.75 M
176.95 M
—
Valuation ratios
Enterprise value
147.36 M
37.84 M
82.04 M
127.62 M
238.26 M
783.92 M
Price to earnings ratio
—
-0.9
-1.1
-0.78
-1.92
-5.48
Price to sales ratio
—
133.37
23.9
9.52
23.61
75.89
Price to cash flow ratio
—
-1.69
-1.77
-0.94
-2.39
-7.62
Price to book ratio
—
2.18
-2.77
-0.84
-2.56
-3.71
Enterprise value to EBITDA ratio
-5.38
-0.25
-1.45
-2.37
-8.37
-18.12
Profitability ratios
Return on assets %
-0.48
-1.73
-1.93
-1.48
-1.43
-1.53
Return on equity %
-0.51
-2.44
22.79
-8.45
-5.3
2.55
Return on invested capital %
-4 002.77
-2 672.42
-877.18
-662.87
-744.95
-621.61
Gross margin %
-17
100
100
100
-41.73
—
Operating margin %
-5 483.8
-14.9 K
-1 996.79
-1 059.64
-1 054.82
—
EBITDA margin %
-5 483
-40.91 K
-1 893.86
-1 032.79
-539.31
—
Net margin %
-5 615.6
-14.9 K
-2 169.11
-1 047.61
-1 232.68
—
Liquidity ratios
Quick ratio
—
—
0.74
1.05
1.3
5.05
Current ratio
22.01
2.89
0.75
1.07
1.31
5.12
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.01
0.08
0.15
0.13
0.08
Solvency ratios
Debt to assets ratio
—
—
0.56
0.69
0.64
2.88
Debt to equity ratio
—
—
-6.6
3.94
2.36
0.25
Long term debt to total assets ratio
—
—
0.51
0.61
0.59
2.67
Long term debt to total equity ratio
—
—
-6.04
3.45
2.19
0.18
Per share metrics
Operating cash flow per share
—
-0.82
-0.79
-0.87
-0.46
-0.51
EBIT per share
—
-4.32
-1.16
-0.91
-0.49
-0.47
EBITDA per share
—
-4.26
-1.1
-0.89
-0.25
-0.46
Total debt per share
—
—
0.37
0.42
0.25
1.27
Cash per share
—
0.62
0.45
0.44
0.34
1.46
Net current asset value per share
—
0.67
0.53
0.5
0.37
1.57
Tangible book value per share
—
0.54
-0.54
-0.99
-0.43
-2.05
Working capital per share
—
0.44
-0.18
0.03
0.09
0.22
Book value per share
—
0.64
-0.5
-0.97
-0.43
-2.03
Haberler
PAVmed 45 milyon dolarlık finansmanı tamamladı
BTIG, Lucid Diagnostics hissesi için tavsiyesini korudu
Lucid Diagnostics Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:LUCD) 2026-03-27
Lucid Diagnostics Inc. (LUCD) Q4 2025 Earnings Call Transcript
Needham, Lucid Diagnostics hissesi için Al tavsiyesini yineledi
Lucid Diagnostics hisse senedi EPS kaybına rağmen yükseldi
Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates
Canaccord, Lucid Diagnostics hissesi için Al tavsiyesini yineledi
DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates
Teleflex (TFX) Q4 Earnings and Revenues Miss Estimates